Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

Renowned medical expert, Professor Sani Al-Hassan, has attributed the increasing cases of kidney diseases in Nigeria to the ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control ...

Globally, COPD is also a leading cause of death. Data from the World Health Organization in 2021 ranked it as the fourth ...

Our mission is to provide a state-of-the-art facility, expertise, and education in advanced quantitative light microscopy to support Drexel University’s research community The Cell Imaging Center (CIC ...

Chronic kidney disease is a progressive condition that reduces kidney function, that is its ability to filter waste from the blood.

The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.

A Bradford Grammar School pupil is leading the ROW2025 challenge to raise funds for a kidney research charity in honour of ...

The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.